Diagnos Laboratorium Utama Tbk. vs RMK Energy Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while RMK Energy Tbk. trades at Rp2,480 (market cap 9.89T, 38.36M 24h volume). The key difference: RMK Energy Tbk. is far larger — about 31.8× Diagnos Laboratorium Utama Tbk.'s market cap, and RMK Energy Tbk. is more actively traded (38.36M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | RMKE | |
|---|---|---|
Market Cap | 310.75B | 9.89T |
Volume | 963.6K | 38.36M |
Lot | 9.64K | 383.59K |
Turnover | 217.67M | 92.82B |
Average Price | 225.89 | 2,419.76 |
Value | 217.67M | 92.82B |
Indicative Equilibrium Price | 226 | 2,480 |
Indicative Equilibrium Volume | 1K | 8.79K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT RMK Energy Tbk (the Company) was established based on Notarial Deed No. 60 of Roslina Sari Hendarto, S.H., dated June 22, 2009. The Company has started its operations since March 2011
Read more on RMKE →